Immediate Impact
2 from Science/Nature 57 standout
Citing Papers
Thyroid Cancer
2024 Standout
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma
2023 Standout
Works of Frederick Millard being referenced
Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma
2014
Final results of a multicenter, open-label phase II trial of dovitinib (TKI258) in patients with advanced urothelial carcinoma with either mutated or nonmutated FGFR3.
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Frederick Millard | 542 | 329 | 245 | 405 | 337 | 45 | 1.2k | |
| Giorgio Bovo | 464 | 485 | 293 | 412 | 205 | 62 | 1.5k | |
| Wei Deng | 395 | 384 | 281 | 325 | 283 | 87 | 1.4k | |
| Véronique D’Hondt | 329 | 763 | 138 | 287 | 161 | 81 | 1.3k | |
| J. Garcia‐Vargas | 401 | 486 | 107 | 494 | 167 | 61 | 1.1k | |
| N. Schleucher | 601 | 789 | 353 | 591 | 160 | 32 | 1.6k | |
| Carlyn Tan | 417 | 521 | 202 | 284 | 164 | 59 | 1.2k | |
| J J Costanzi | 281 | 635 | 131 | 293 | 187 | 36 | 1.2k | |
| Giuseppe Fornarini | 524 | 560 | 291 | 224 | 160 | 123 | 1.2k | |
| Terukazu Nakamura | 364 | 346 | 210 | 563 | 156 | 70 | 1.3k | |
| Shigeo Aizawa | 415 | 405 | 314 | 404 | 128 | 56 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...